Spectrophotometric, spectrofluorimetric, HPLC and CZE determination of mirtazapine in pharmaceutical tablets

被引:16
作者
Labat, L [1 ]
Dallet, P [1 ]
Kummer, E [1 ]
Dubost, JP [1 ]
机构
[1] Fac Pharm, Chim Analyt Lab, F-33076 Bordeaux, France
关键词
mirtazapine; tablets; analysis; UV spectrophotometry; spectrofluorimetry; HPLC; CZE;
D O I
10.1016/S0731-7085(01)00625-2
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Four analytical methods have been developed for the quality control of tablets containing mirtazapine: spectrophotometry, spectrofluorimetry, high performance liquid chromatography (HPLC) and capillary zone electrophoresis (CZE). All the methods only require a simple extraction procedure of mirtazapine from the tablets before analysis. The concentration of mirtazapine in solutions was determined in the linearity range of 5-25 mug/ml at = 315 nm for spectrophotometry and at lambda = 220 nm for HPLC and CZE. Spectrofluorimetric determinations were achieved at lambda(excitation) = 328 nm and lambda(emission) = 415 nm in the linearity range of 2-25 ng/ml. All the methods gave similar results and were validated for selectivity, linearity, precision and sensitivity. Spectrometric methods gave slightly higher RSD values (up to 2.54%). The four methods were directly and easily applied to the pharmaceutical preparation with accuracy, resulting from recovery experiments between 99.72% in HPLC and 101.47% in spectrofluorimetry. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:365 / 371
页数:7
相关论文
共 11 条
[1]   Chiral determination of mirtazapine in human blood plasma by high-performance liquid chromatography [J].
Dodd, S ;
Burrows, GD ;
Norman, TR .
JOURNAL OF CHROMATOGRAPHY B, 2000, 748 (02) :439-443
[2]  
Gorman JM, 1999, J CLIN PSYCHIAT, V60, P9
[3]   Determination of mirtazapine in tablets by UV spectrophotometric and derivative spectrophotometric methods [J].
Karasen, N ;
Altinöz, S .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 24 (01) :11-17
[4]   A comparison of the physicochemical and biological properties of mirtazapine and mianserin [J].
Kelder, J ;
Funke, C ;
DeBoer, T ;
Delbressine, L ;
Leysen, D ;
Nickolson, V .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (04) :403-411
[5]   Comparison of high-performance liquid chromatography and capillary zone electrophoresis for the determination of parabens in a cosmetic product [J].
Labat, L ;
Kummer, E ;
Dallet, P ;
Dubost, JP .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2000, 23 (04) :763-769
[6]  
LABAT L, 2000, ANN TOXICOL ANAL, V12, P171
[7]   High-performance liquid chromatographic assay with fluorescence detection for the routine monitoring of the antidepressant mirtazapine and its demethyl metabolite in human plasma [J].
Maris, FA ;
Dingler, E ;
Niehues, S .
JOURNAL OF CHROMATOGRAPHY B, 1999, 721 (02) :309-316
[8]   CAPILLARY GAS-CHROMATOGRAPHIC ASSAY FOR THE ROUTINE MONITORING OF THE ANTIDEPRESSANT MEPIRZEPINE IN HUMAN-PLASMA [J].
PAANAKKER, JE ;
VANHAL, HJM .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 417 (01) :203-207
[9]   Mirtazapine pharmacokinetics with two dosage regimens and two pharmaceutical formulations [J].
Timmer, CJ ;
Paanakker, JE ;
VrijmoeddeVries, M .
PHARMACEUTICAL RESEARCH, 1997, 14 (01) :98-102
[10]   Development and validation of a capillary electrophoresis method within a pharmaceutical quality control environment and comparison with high-performance liquid chromatography [J].
Wynia, GS ;
Windhorst, G ;
Post, PC ;
Maris, FA .
JOURNAL OF CHROMATOGRAPHY A, 1997, 773 (1-2) :339-350